Objectives

1) Review recent technology , new drugs/insulin in Diabetes
2) Review new glucose monitoring devices and goals
3) Review 2020 ADA guidelines and CV outcome data related to pharmacological agents in T2DM

 

Faculty

Ibitoro Osakwe, MD
Chief, Endocrine & Diabetes Metabolism
UMASS Medical School - Baystate
Baystate Medical Center

 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.   

Session date: 
Tuesday, September 15, 2020 - 12:00pm to 1:00pm
Location: 
Baystate Medical Center WEBEX
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.